Professional Documents
Culture Documents
DRUG STUDY - Prucalopride
DRUG STUDY - Prucalopride
PATIENT’S INFORMATION
Name of Patient: Patient R.C.E Age: 70 Sex: Female Chief Complaint: Abdominal Pain
Diagnosis: T/C Paralytic Ileus; Colonic Diverticulitis; Erosive Gastritis;T/C CAP MR; Hypertension St.II
uncontrolled
DRUG INFORMATION
Drug Classification: Prokinetic Agents Generic Name: Prucalopride
Dosage: 1mg TAB OD Brand Name: Motegrity, Resolor, Resotran
Route of Administration: PO
INDICATION CONTRAINDICATION
Prucalopride is indicated for the treatment of chronic Intestinal perforation or obstruction due to the
idiopathic constipation (CIC) in adults. CIC is one of structural or functional disorder of gut wall,
the most common chronic functional gastrointestinal obstructive ileus, severe inflammatory conditions of
disorders worldwide. The diagnosis of this agent is
the intestinal tract (e.g., Crohn disease, ulcerative
very hard and it can be confirmed if the patient
experience at least two of the following: colitis, toxic megacolon/megarectum)
• headache
• abdominal pain or bloating
• nausea
• diarrhea
• dizziness
• vomiting
• gas
• fatigue
ADVERSE REACTIONS:
FOOD: None
LAB: None
HEALTH TEACHING
• Instruct patient to take prucalopride as directed. Advise patient to read Patient Information before
starting therapy and with each Rx refill in case of changes.
• Instruct patient to notify health care professional of all Rx or OTC medications, vitamins, or herbal
products being taken and consult health care professional before taking any new medications.